IP Verse

Use Of Il-22 Dimer In Manufacture Of A Medicament For Intravenous Administration

Patent No. EP3065763 (titled "Use Of Il-22 Dimer In Manufacture Of A Medicament For Intravenous Administration") was filed by Evive Biotechnology Shanghai on Nov 6, 2014. The application was issued on Nov 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJun 1, 2021MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3065763

EVIVE BIOTECHNOLOGY SHANGHAI
Application Number
EP14860301A
Filing Date
Nov 6, 2014
Status
Patent Maintained As Amended
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register , Google Patents